A phase 2b randomized, double-blind, parallel-group, placebo-controlled, dose-finding study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of GSK1070806 administered by subcutaneous injection in adult participants with moderate to severe atopic dermatitis.